Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.860
-0.190 (-4.69%)
May 28, 2026, 3:53 PM HKT

HKG:2563 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
28.6571.8766.6432.8271.06
Other Revenue
4.72----
33.3671.8766.6432.8271.06
Revenue Growth (YoY)
-53.57%7.85%103.03%-53.82%-
Cost of Revenue
2.629.8119.818.944.17
Gross Profit
30.7462.0546.8323.8866.89
Selling, General & Admin
65.61114.2139.3149.41267.37
Research & Development
82.99116.29126.5482.7491.97
Other Operating Expenses
1.091.04-1.25-15.250.96
Operating Expenses
170.34231.82263.3218.11360.69
Operating Income
-139.6-169.77-216.47-194.23-293.79
Interest Expense
-0.05-0.06-0.06-0.07-0.07
Interest & Investment Income
16.3418.3513.143.3414.11
Currency Exchange Gain (Loss)
-10.185.544.6519.6-4.9
Other Non Operating Income (Expenses)
-0.05-0.05---0.03
EBT Excluding Unusual Items
-133.53-145.99-198.74-171.36-284.68
Gain (Loss) on Sale of Investments
-0.050.499.110.858.46
Asset Writedown
-2.36-0.29---
Other Unusual Items
4.512.01---1.92
Pretax Income
-131.44-143.78-189.64-160.51-278.14
Net Income
-131.44-143.78-189.64-160.51-278.14
Net Income to Common
-131.44-143.78-189.64-160.51-278.14
Shares Outstanding (Basic)
365351350350350
Shares Outstanding (Diluted)
365351350350350
Shares Change (YoY)
4.11%0.19%---
EPS (Basic)
-0.36-0.41-0.54-0.46-0.79
EPS (Diluted)
-0.36-0.41-0.54-0.46-0.79
Free Cash Flow
-156.94-153.39-178.62-111.3-89.83
Free Cash Flow Per Share
-0.43-0.44-0.51-0.32-0.26
Gross Margin
92.13%86.35%70.27%72.76%94.13%
Operating Margin
-418.41%-236.23%-324.87%-591.81%-413.42%
Profit Margin
-393.94%-200.06%-284.60%-489.06%-391.40%
Free Cash Flow Margin
-470.38%-213.45%-268.05%-339.12%-126.41%
EBITDA
-130.12-161.08-207.3-185.14-286.11
EBITDA Margin
--224.14%---
D&A For EBITDA
9.488.689.179.17.69
EBIT
-139.6-169.77-216.47-194.23-293.79
EBIT Margin
--236.23%---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.